ONCY

ONCOLYTICS BIOTECH INC

Healthcare · Biotechnology

$180.97 sample

-2.76 (-1.50%) 1D

Market cap

$899.2B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-01

Alerts

8

Price$180.97 +5.31% 3M daily closessample

189.40167.98

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: Chief Executive Officer
Oct 01SECForm 144 filed
Sep 24SECForm 144 filed
Sep 21INSInsider sell: EVP, Operations
Sep 14INSInsider sell: Chief Financial Officer
Sep 04INSInsider buy: General Counsel
Aug 26SECDEF 14A filed
Aug 18INSInsider buy: Chief Executive Officer

Sign up to see the real ONCY record →

Company facts

SEC EDGAR registration

Name: ONCOLYTICS BIOTECH INC
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +33sample, -100 to +100
Reporting currency: USD

Who is positioning in ONCY

sample

Insiders: 30 insider transactions over 90 days, net selling, $248.4M
Congress: 2 members traded over 90 days
Institutions · 13F: 31 funds hold $5.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$48.0B +14.2% y/y

Q4 2024Q3 2026

Inventory$29.9B +14.5% y/y

Q4 2024Q3 2026

Accounts receivable$22.8B +13.9% y/y

Q4 2024Q3 2026

Total debt$57.8B +9.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $262.1B +3.8% 3M
Sample peer B: $281.2B -10.6% 3M
Sample peer C: $877.9B +9.2% 3M
Sample peer D: $347.2B -0.4% 3M
Sample peer E: $817.5B +7.8% 3M